Loading company…
ID 404659767 · FY 2023–2024 · 2 years
კომპანიის ძირითად საქმიანობას წარმოადგენს რენტგენის სამრეწველო დანადგარების და სათადარიგო ნაწილების შესყიდვა და რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Net Cash from Operating Activities | 2,101 | 765 | -63.6% |
| Net Cash used in Investing Activities | -72 | -4 | -95.1% |
| Free Cash Flow (OCF − Capex proxy) | 2,029 | 762 | -62.5% |
| Net Cash from Financing Activities | -955 | -1,290 | +35.1% |
| Net Change in Cash (before FX) | 1,074 | -528 | nmf |
| Effect of FX on Cash | -60 | 27 | nmf |
| Net Change in Cash (incl. FX) | 1,014 | -501 | nmf |
| Cash at Beginning of Year | 4 | 1,017 | nmf |
| Cash at End of Year | 1,017 | 517 | -49.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).